GlobeNewswire 24/09/2013 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire 26/07/2013 Bellevue Group remains profitable despite low turnovers
GlobeNewswire 18/07/2013 Biotech sector continues to perform well / valuations still at attractive levels despite strong sect...
GlobeNewswire 28/06/2013 BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...
GlobeNewswire 19/06/2013 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire 18/04/2013 Biotech sector maintains upward trend in first quarter / BB Biotech outperforms its benchmark again
GlobeNewswire 26/03/2013 Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
GlobeNewswire 18/03/2013 Shareholders at BB Biotech's Annual General Meeting approve cash distribution of CHF 4.50 per share ...
GlobeNewswire 18/03/2013 L'Assemblea generale di BB Biotech autorizza la distribuzione in contanti di CHF 4.50 per azione / n...
GlobeNewswire 14/03/2013 BB Biotech AG completed its current share buyback program
GlobeNewswire 14/03/2013 Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
GlobeNewswire 25/02/2013 Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
GlobeNewswire 25/02/2013 Bellevue Group returns to profitability - impressive investment performance
GlobeNewswire 21/02/2013 Publication of the annual report 2012 of BB Biotech AG
GlobeNewswire 24/01/2013 Biotech sector still attractively valued despite its rally
GlobeNewswire 16/01/2013 BB Biotech AG earns after-tax profits of CHF 368 million in fiscal 2012
GlobeNewswire 16/01/2013 Ad hoc: BB Biotech AG earns after-tax profits of CHF 368 million in fiscal 2012
GlobeNewswire 20/11/2012 Vontobel Group withdraws its proposal to restructure BB Biotech AG into an unlisted investment fund
GlobeNewswire 18/10/2012 BB Biotech reports strong third quarter results
GlobeNewswire 07/09/2012 BB Biotech returns to TecDAX
GlobeNewswire 19/07/2012 BB BIOTECH AG: Sustainable increase of value for the company and its shareholders
GlobeNewswire 19/07/2012 BB Biotech announces structured distribution policy and specifies reasons for rejection of the propo...
GlobeNewswire 13/07/2012 BB Biotech rejects proposal by Vontobel Group
GlobeNewswire 13/07/2012 BB Biotech AG with net profit after tax of CHF 354 mn for the first half of 2012
GlobeNewswire 13/07/2012 Ad hoc: BB Biotech AG with net profit after tax of CHF 354 mn for the first half of 2012